344 related articles for article (PubMed ID: 23432691)
1. Macrophages in multiple myeloma: emerging concepts and therapeutic implications.
Asimakopoulos F; Kim J; Denu RA; Hope C; Jensen JL; Ollar SJ; Hebron E; Flanagan C; Callander N; Hematti P
Leuk Lymphoma; 2013 Oct; 54(10):2112-21. PubMed ID: 23432691
[TBL] [Abstract][Full Text] [Related]
2. Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma.
Jensen JL; Rakhmilevich A; Heninger E; Broman AT; Hope C; Phan F; Miyamoto S; Maroulakou I; Callander N; Hematti P; Chesi M; Bergsagel PL; Sondel P; Asimakopoulos F
Cancer Immunol Res; 2015 Aug; 3(8):881-90. PubMed ID: 25941352
[TBL] [Abstract][Full Text] [Related]
3. MAP3K8 kinase regulates myeloma growth by cell-autonomous and non-autonomous mechanisms involving myeloma-associated monocytes/macrophages.
Hebron E; Hope C; Kim J; Jensen JL; Flanagan C; Bhatia N; Maroulakou I; Mitsiades C; Miyamoto S; Callander N; Hematti P; Asimakopoulos F
Br J Haematol; 2013 Mar; 160(6):779-84. PubMed ID: 23252623
[TBL] [Abstract][Full Text] [Related]
4. Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells.
Kim J; Denu RA; Dollar BA; Escalante LE; Kuether JP; Callander NS; Asimakopoulos F; Hematti P
Br J Haematol; 2012 Aug; 158(3):336-46. PubMed ID: 22583117
[TBL] [Abstract][Full Text] [Related]
5. The IKZF1-IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated Macrophages.
Mougiakakos D; Bach C; Böttcher M; Beier F; Röhner L; Stoll A; Rehli M; Gebhard C; Lischer C; Eberhardt M; Vera J; Büttner-Herold M; Bitterer K; Balzer H; Leffler M; Jitschin S; Hundemer M; Awwad MHS; Busch M; Stenger S; Völkl S; Schütz C; Krönke J; Mackensen A; Bruns H
Cancer Immunol Res; 2021 Mar; 9(3):265-278. PubMed ID: 33563611
[TBL] [Abstract][Full Text] [Related]
6. Macrophages in multiple myeloma: key roles and therapeutic strategies.
Opperman KS; Vandyke K; Psaltis PJ; Noll JE; Zannettino ACW
Cancer Metastasis Rev; 2021 Mar; 40(1):273-284. PubMed ID: 33404860
[TBL] [Abstract][Full Text] [Related]
7. Ribosomal proteins as distinct "passengers" of microvesicles: new semantics in myeloma and mesenchymal stem cells' communication.
Dabbah M; Lishner M; Jarchowsky-Dolberg O; Tartakover-Matalon S; Brin YS; Pasmanik-Chor M; Neumann A; Drucker L
Transl Res; 2021 Oct; 236():117-132. PubMed ID: 33887527
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells-macrophages crosstalk and myeloid malignancy.
Li K; Nie H; Jin R; Wu X
Front Immunol; 2024; 15():1397005. PubMed ID: 38779660
[TBL] [Abstract][Full Text] [Related]
9. Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes.
Jafarzadeh N; Safari Z; Pornour M; Amirizadeh N; Forouzandeh Moghadam M; Sadeghizadeh M
J Cell Physiol; 2019 Apr; 234(4):3697-3710. PubMed ID: 30317554
[TBL] [Abstract][Full Text] [Related]
10. Macrophages in multiple myeloma.
Ribatti D; Moschetta M; Vacca A
Immunol Lett; 2014 Oct; 161(2):241-4. PubMed ID: 24370642
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?
Xu S; De Veirman K; De Becker A; Vanderkerken K; Van Riet I
Leukemia; 2018 Jul; 32(7):1500-1514. PubMed ID: 29535427
[TBL] [Abstract][Full Text] [Related]
12. Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization.
Philipp D; Suhr L; Wahlers T; Choi YH; Paunel-Görgülü A
Stem Cell Res Ther; 2018 Oct; 9(1):286. PubMed ID: 30359316
[TBL] [Abstract][Full Text] [Related]
13. Pericentromeric Non-Coding DNA Transcription Is Associated with Niche Impairment in Patients with Ineffective or Partially Effective Multiple Myeloma Treatment.
Enukashvily NI; Semenova N; Chubar AV; Ostromyshenskii DI; Gushcha EA; Gritsaev S; Bessmeltsev SS; Rugal VI; Prikhodko EM; Kostroma I; Zherniakova A; Kotova AV; Belik LA; Shumeev A; Maslennikova II; Ivolgin DI
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328779
[TBL] [Abstract][Full Text] [Related]
14. The Macrophage Response Is Driven by Mesenchymal Stem Cell-Mediated Metabolic Reprogramming.
Luque-Campos N; Bustamante-Barrientos FA; Pradenas C; García C; Araya MJ; Bohaud C; Contreras-López R; Elizondo-Vega R; Djouad F; Luz-Crawford P; Vega-Letter AM
Front Immunol; 2021; 12():624746. PubMed ID: 34149687
[TBL] [Abstract][Full Text] [Related]
15. CD28 expressed on malignant plasma cells induces a prosurvival and immunosuppressive microenvironment.
Nair JR; Carlson LM; Koorella C; Rozanski CH; Byrne GE; Bergsagel PL; Shaughnessy JP; Boise LH; Chanan-Khan A; Lee KP
J Immunol; 2011 Aug; 187(3):1243-53. PubMed ID: 21715687
[TBL] [Abstract][Full Text] [Related]
16. Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer.
Li W; Zhang X; Wu F; Zhou Y; Bao Z; Li H; Zheng P; Zhao S
Cell Death Dis; 2019 Dec; 10(12):918. PubMed ID: 31801938
[TBL] [Abstract][Full Text] [Related]
17. Human Mesenchymal Stem Cell-Educated Macrophages Are a Distinct High IL-6-Producing Subset that Confer Protection in Graft-versus-Host-Disease and Radiation Injury Models.
Bouchlaka MN; Moffitt AB; Kim J; Kink JA; Bloom DD; Love C; Dave S; Hematti P; Capitini CM
Biol Blood Marrow Transplant; 2017 Jun; 23(6):897-905. PubMed ID: 28257800
[TBL] [Abstract][Full Text] [Related]
18. miR-34a promotes the immunosuppressive function of multiple myeloma-associated macrophages by dampening the TLR-9 signaling.
Zhang R; Zhang D; Luo Y; Sun Y; Duan C; Yang J; Wei J; Li X; Lu Y; Lai X
Cancer Med; 2024 Jun; 13(11):e7387. PubMed ID: 38864479
[TBL] [Abstract][Full Text] [Related]
19. Clodronate-Liposome Mediated Macrophage Depletion Abrogates Multiple Myeloma Tumor Establishment In Vivo.
Opperman KS; Vandyke K; Clark KC; Coulter EA; Hewett DR; Mrozik KM; Schwarz N; Evdokiou A; Croucher PI; Psaltis PJ; Noll JE; Zannettino AC
Neoplasia; 2019 Aug; 21(8):777-787. PubMed ID: 31247457
[TBL] [Abstract][Full Text] [Related]
20. Exosome-derived miR-let-7c promotes angiogenesis in multiple myeloma by polarizing M2 macrophages in the bone marrow microenvironment.
Tian X; Sun M; Wu H; Chen C; Li H; Qiu S; Wang T; Han J; Xiao Q; Chen K
Leuk Res; 2021 Jun; 105():106566. PubMed ID: 33848709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
